Hints and tips:
Related Special Reports
...Describing the vaccine rollout in December 2020, he said: “It’s clear in the first half, the away team gave us an absolute battering . . . In the 70th minute we’ve now got an equaliser....
...fastest-growing practice in 2023, even as business leaders were less vocal on environmental, social and governance issues compared with a few years ago, referring to the backlash in some countries, including the US...
...However, a week later, you reported (April 12) that Moderna, the US biotech company, was shelving plans to build a $200mn vaccine plant in Kenya....
...Another case in the federal court of Massachusetts has recently been paused pending a decision by the US Patent Office on whether two of three Moderna patents under dispute there are valid....
...US biotech Moderna has put plans to build a vaccine plant in Kenya on hold, in a sign that moves to invest in pandemic preparedness in Africa have dropped down the agenda as sales of Covid-19 jabs decline...
...Moderna paid $1,053,767 for security services to Stéphane Bancel, after not disclosing any security payments for him the previous year....
...US-based hedge fund Shah Capital wrote to the Novavax board on Monday to push for the instalment of two new independent board directors....
...US energy provider Avangrid rose 3.3 per cent after its Spanish parent Iberdrola called off its $8.3bn acquisition of US-based PNM Resources....
...That has unnerved the lawyers who believe the state’s reputation for predictability is eroding, potentially risking its status as the premier place for US businesses to incorporate....
...Falling demand for Covid-19 shots in the US means Moderna now expects full year sales of at least $6bn, at the lower end of its previous guidance and below the consensus forecast for $6.5bn....
...Can Moderna be more than a one-hit wonder? The US biotech company hit the ultimate home run when it became one of the first to develop a Covid-19 vaccine. But that demand has fallen dramatically....
...Moderna and CureVac have also issued legal proceedings against the US and German partners, with the aim of obtaining a share of Comirnaty profits but also asserting their intellectual property for future...
...But Moderna said that waning demand for Covid vaccines in the US meant its full-year sales would be at least $6bn, the lower end of its previous guidance and below analysts’ forecast for $6.6bn....
...The S&P 500 added 0.1 per cent on Tuesday, with biotech group Moderna the best performing stock, up 6.2 per cent. Real estate and utilities were the best performing sectors on the day....
...The US federal drug regulator has approved new Covid-19 boosters from Moderna and Pfizer, as it moves to contain infections from spreading more quickly in the US....
...Moderna’s combined Covid-19 and influenza vaccine was as effective as separate shots in an early stage trial, giving the US biotech company hope that the more convenient way of protecting against the diseases...
...Stephen Hoge, Moderna’s president, told the Financial Times that in the past year, Moderna had quickly learned how to improve the shot....
...Few companies have enjoyed the kind of extraordinary rise in fortunes like Moderna. The US biotech company, founded in 2010, never made a profit in the first decade of its existence....
Case studies in best practice among general counsel and company legal teams in North America
...Brussels is negotiating a new Covid-19 vaccine procurement deal with US drugmaker Moderna as EU health authorities grow concerned about a rise in coronavirus infections....
...Moderna shares jumped almost 9 per cent, putting it among the top performers in the S&P 500 after a Chinese biotechnology firm announced a collaboration with the US mRNA vaccine maker....
...Moderna raised its sales forecast for its Covid-19 jab on Thursday as it prepares for the introduction of private market sales in the US....
...The same concerns have plagued other drugmakers whose sales surged during the pandemic, such as Moderna and Pfizer’s partner BioNTech....
International Edition